Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
ViewRay seeing order book momentum into year-end, says Piper Sandler » 04:42
09/27/22
09/27
04:42
09/27/22
04:42
VRAY

ViewRay

$3.53 /

-0.16 (-4.34%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar keeps an Overweight rating on ViewRay with a $6 price target after hosting investor meetings with management. There's a "great deal of internal optimism" at the company due to continued order strength during Q3, including several key wins that management has publicly announced, Bednar tells investors in a research note. The analyst says this should have positive implications for order book momentum into year-end. He continues to view the business as having one of the best growth outlooks and the stock as having "some of the best pure upside potential across small-cap medtech."

ShowHide Related Items >><<
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

  • 17
    Nov
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

Over a week ago
Conference/Events
ViewRay management to meet virtually with Piper Sandler » 04:55
09/23/22
09/23
04:55
09/23/22
04:55
VRAY

ViewRay

$3.79 /

-0.18 (-4.53%)

Virtual Meeting to be…

Virtual Meeting to be held on September 23 hosted by Piper Sandler.

ShowHide Related Items >><<
VRAY ViewRay
$3.79 /

-0.18 (-4.53%)

VRAY ViewRay
$3.79 /

-0.18 (-4.53%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.79 /

-0.18 (-4.53%)

  • 17
    Nov
VRAY ViewRay
$3.79 /

-0.18 (-4.53%)

Hot Stocks
ViewRay announces MD Anderson Cancer Center purchase of MRIdian therapy system » 06:35
09/20/22
09/20
06:35
09/20/22
06:35
VRAY

ViewRay

$3.67 /

-0.04 (-1.08%)

ViewRay announced that…

ViewRay announced that the University of Texas MD Anderson Cancer Center in Houston, Texas purchased a MRIdian MR-Guided Radiation Therapy System. This will be the first MRIdian system to be installed at MD Anderson main campus at the Texas Medical Center in Houston, Texas.

ShowHide Related Items >><<
VRAY ViewRay
$3.67 /

-0.04 (-1.08%)

VRAY ViewRay
$3.67 /

-0.04 (-1.08%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.67 /

-0.04 (-1.08%)

  • 17
    Nov
VRAY ViewRay
$3.67 /

-0.04 (-1.08%)

Conference/Events
ViewRay management to meet virtually with Piper Sandler » 16:05
09/19/22
09/19
16:05
09/19/22
16:05
VRAY

ViewRay

$3.69 /

-0.015 (-0.40%)

Virtual Meeting to be…

Virtual Meeting to be held on September 23 hosted by Piper Sandler.

ShowHide Related Items >><<
VRAY ViewRay
$3.69 /

-0.015 (-0.40%)

VRAY ViewRay
$3.69 /

-0.015 (-0.40%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.69 /

-0.015 (-0.40%)

  • 17
    Nov
VRAY ViewRay
$3.69 /

-0.015 (-0.40%)

Hot Stocks
ViewRay announces GenesisCare purchases two additional MRIdian systems » 06:32
09/08/22
09/08
06:32
09/08/22
06:32
VRAY

ViewRay

$3.48 /

+0.225 (+6.92%)

ViewRay announced that…

ViewRay announced that GenesisCare has purchased two additional MRIdian MRI-guided radiation therapy systems for installation at new-build comprehensive cancer centers in Guildford and Birmingham. These latest acquisitions will double the UK footprint to four systems, which currently includes those in Oxford and London, and will bring the total number of systems in the GenesisCare global network to six, including systems in the USA and Spain, within the next two years.

ShowHide Related Items >><<
VRAY ViewRay
$3.48 /

+0.225 (+6.92%)

VRAY ViewRay
$3.48 /

+0.225 (+6.92%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.48 /

+0.225 (+6.92%)

  • 17
    Nov
VRAY ViewRay
$3.48 /

+0.225 (+6.92%)

Recommendations
ViewRay approval 'another nice positive' for story, says Piper Sandler » 09:03
09/07/22
09/07
09:03
09/07/22
09:03
VRAY

ViewRay

$3.25 /

-0.075 (-2.26%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar reiterates an Overweight rating on ViewRay with a $6 price target after the company announced that its MRIdian System has received China National Medical Products Administration approval. The move came earlier than expected and clears a key regulatory hurdle for ViewRay to begin commercial operations in the "under penetrated but fast-growing" radiation therapy market, Bednar tells investors in a research note. He views the news as "another nice positive" for the ViewRay story saying it allows the company to begin selling in the second-largest radiation therapy market in the world.

ShowHide Related Items >><<
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
02/11/22 Piper Sandler
ViewRay should be bought on recent weakness, says Piper Sandler
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

  • 17
    Nov
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

Hot Stocks
ViewRay announces China NMPA approval for MRIdian Therapy System » 06:33
09/07/22
09/07
06:33
09/07/22
06:33
VRAY

ViewRay

$3.25 /

-0.075 (-2.26%)

ViewRay announced that…

ViewRay announced that the company's MRIdian MRI-Guided Radiation Therapy System has received approval from the Chinese regulatory authority National Medical Products Administration, or NMPA, allowing for its sale and utilization throughout China. This approval expands MRIdian's global reach and offers cancer patients a new radiation therapy option, MRIdian Stereotactic MRI-Guided Adaptive Radiotherapy, or SMART, allowing treatment that integrates diagnostic-quality MR imaging, on-table adaptive replanning, and continuous, real-time, soft tissue tracking and automated beam gating.

ShowHide Related Items >><<
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
02/11/22 Piper Sandler
ViewRay should be bought on recent weakness, says Piper Sandler
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

  • 17
    Nov
VRAY ViewRay
$3.25 /

-0.075 (-2.26%)

Over a month ago
Hot Stocks
ViewRay announces VA Houston Healthcare System selects MRIdian system » 06:34
08/23/22
08/23
06:34
08/23/22
06:34
VRAY

ViewRay

$3.57 /

+0.005 (+0.14%)

ViewRay announced that…

ViewRay announced that the VA Houston Healthcare System has selected a MRIdian MRI-guided radiation therapy system to expand radiation therapy services at the Michael E. DeBakey VA Medical Center. The MRIdian system will enable the VA Houston Cancer Program to offer advanced MRI-guided radiation therapy technology to Veterans throughout the region who are seeking personalized treatment for pancreas, prostate, lung, liver, breast, and oligometastatic cancers.

ShowHide Related Items >><<
VRAY ViewRay
$3.57 /

+0.005 (+0.14%)

VRAY ViewRay
$3.57 /

+0.005 (+0.14%)

08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
02/11/22 Piper Sandler
ViewRay should be bought on recent weakness, says Piper Sandler
VRAY ViewRay
$3.57 /

+0.005 (+0.14%)

  • 17
    Nov
VRAY ViewRay
$3.57 /

+0.005 (+0.14%)

Options
Unusually active option classes on open August 16th » 09:40
08/16/22
08/16
09:40
08/16/22
09:40
VRAY

ViewRay

$3.81 /

+ (+0.00%)

, GEO

Geo Group

$7.55 /

+ (+0.00%)

, HD

Home Depot

$314.68 /

+0.41 (+0.13%)

, WMT

Walmart

$132.58 /

+ (+0.00%)

, NKLA

Nikola

$6.73 /

+0.005 (+0.07%)

, SE

Sea Limited

$90.00 /

+0.065 (+0.07%)

, EQT

EQT Corporation

$45.15 /

-0.045 (-0.10%)

, TGT

Target

$172.27 /

-0.03 (-0.02%)

, RKT

Rocket Companies

$10.66 /

+0.015 (+0.14%)

, ACB

Aurora Cannabis

$1.88 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: ViewRay (VRAY), GEO Group (GEO), Home Depot (HD), Wal-Mart (WMT), Nikola (NKLA), Sea Limited (SE), EQT Corporation (EQT), Target (TGT), Rocket Companies (RKT), and Aurora Cannabis (ACB).

ShowHide Related Items >><<
WMT Walmart
$132.58 /

+ (+0.00%)

VRAY ViewRay
$3.81 /

+ (+0.00%)

TGT Target
$172.27 /

-0.03 (-0.02%)

SE Sea Limited
$90.00 /

+0.065 (+0.07%)

RKT Rocket Companies
$10.66 /

+0.015 (+0.14%)

NKLA Nikola
$6.73 /

+0.005 (+0.07%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

EQT EQT Corporation
$45.15 /

-0.045 (-0.10%)

ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

VRAY ViewRay
$3.81 /

+ (+0.00%)

08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
02/11/22 Piper Sandler
ViewRay should be bought on recent weakness, says Piper Sandler
GEO Geo Group
$7.55 /

+ (+0.00%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

08/11/22 Citi
Lowe's downgraded to Neutral from Buy at Citi
08/09/22 JPMorgan
Home Depot price target lowered to $311 from $335 at JPMorgan
06/22/22 MKM Partners
Home Depot initiated with a Neutral at MKM Partners
05/20/22 Citi
Home Depot price target raised to $348 from $327 at Citi
WMT Walmart
$132.58 /

+ (+0.00%)

07/29/22 BofA
Amazon price target bumped to $170 at BofA after 'mostly positive' quarter
07/28/22 DA Davidson
Best Buy price target lowered to $88 from $110 at DA Davidson
07/28/22 Wells Fargo
Best Buy price target lowered to $70 from $82 at Wells Fargo
07/27/22 Deutsche Bank
Walmart price target lowered to $142 from $166 at Deutsche Bank
NKLA Nikola
$6.73 /

+0.005 (+0.07%)

08/05/22 Deutsche Bank
Nikola price target raised to $8 from $7 at Deutsche Bank
07/18/22 Deutsche Bank
Nikola price target lowered to $7 from $11 at Deutsche Bank
05/10/22 Wedbush
Nikola price target lowered to $10 from $15 at Wedbush
03/25/22 Wedbush
Nikola's analyst day sets bullish tone for 2022, beyond, says Wedbush
SE Sea Limited
$90.00 /

+0.065 (+0.07%)

07/28/22 Daiwa
Sea Limited price target lowered to $110 from $130 at Daiwa
07/26/22 Citi
Sea Limited price target lowered to $145 from $156 at Citi
07/20/22 Barclays
Sea Limited price target lowered to $125 from $157 at Barclays
07/15/22 Stifel
Sea Limited price target lowered to $105 from $115 at Stifel
EQT EQT Corporation
$45.15 /

-0.045 (-0.10%)

07/25/22 Scotiabank
EQT Corporation assumed with an Outperform at Scotiabank
07/22/22 Piper Sandler
EQT Corporation price target raised to $59 from $58 at Piper Sandler
07/21/22 Citi
EQT Corporation assumed with Buy, $48 target at Citi
07/19/22 Mizuho
EQT Corporation price target lowered to $55 from $65 at Mizuho
TGT Target
$172.27 /

-0.03 (-0.02%)

08/09/22 JPMorgan
Target price target raised to $190 from $180 at JPMorgan
08/01/22 Wells Fargo
Wells Fargo upgrades Target to Overweight, raises price target to $195
08/01/22 Wells Fargo
Target upgraded to Overweight from Equal Weight at Wells Fargo
RKT Rocket Companies
$10.66 /

+0.015 (+0.14%)

08/07/22 Keefe Bruyette
Rocket Companies downgraded to Underperform from Market Perform at Keefe Bruyette
07/11/22 Barclays
Rocket Companies price target lowered to $8 from $11 at Barclays
07/06/22 Wells Fargo
Wells Fargo upgrades Rocket Companies to Overweight, raises price target to $10
07/06/22 Wells Fargo
Rocket Companies upgraded to Overweight from Equal Weight at Wells Fargo
ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
WMT Walmart
$132.58 /

+ (+0.00%)

VRAY ViewRay
$3.81 /

+ (+0.00%)

TGT Target
$172.27 /

-0.03 (-0.02%)

SE Sea Limited
$90.00 /

+0.065 (+0.07%)

RKT Rocket Companies
$10.66 /

+0.015 (+0.14%)

NKLA Nikola
$6.73 /

+0.005 (+0.07%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

GEO Geo Group
$7.55 /

+ (+0.00%)

EQT EQT Corporation
$45.15 /

-0.045 (-0.10%)

ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

  • 27
    May
  • 04
    Jan
  • 19
    Nov
  • 17
    Nov
  • 29
    Sep
  • 10
    Sep
WMT Walmart
$132.58 /

+ (+0.00%)

TGT Target
$172.27 /

-0.03 (-0.02%)

SE Sea Limited
$90.00 /

+0.065 (+0.07%)

NKLA Nikola
$6.73 /

+0.005 (+0.07%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

GEO Geo Group
$7.55 /

+ (+0.00%)

EQT EQT Corporation
$45.15 /

-0.045 (-0.10%)

ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

WMT Walmart
$132.58 /

+ (+0.00%)

TGT Target
$172.27 /

-0.03 (-0.02%)

SE Sea Limited
$90.00 /

+0.065 (+0.07%)

RKT Rocket Companies
$10.66 /

+0.015 (+0.14%)

NKLA Nikola
$6.73 /

+0.005 (+0.07%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

WMT Walmart
$132.58 /

+ (+0.00%)

VRAY ViewRay
$3.81 /

+ (+0.00%)

TGT Target
$172.27 /

-0.03 (-0.02%)

SE Sea Limited
$90.00 /

+0.065 (+0.07%)

RKT Rocket Companies
$10.66 /

+0.015 (+0.14%)

NKLA Nikola
$6.73 /

+0.005 (+0.07%)

HD Home Depot
$314.68 /

+0.41 (+0.13%)

EQT EQT Corporation
$45.15 /

-0.045 (-0.10%)

ACB Aurora Cannabis
$1.88 /

+ (+0.00%)

Hot Stocks
ViewRay to move its headquarters to Denver » 06:07
08/08/22
08/08
06:07
08/08/22
06:07
VRAY

ViewRay

$3.40 /

+0.115 (+3.50%)

ViewRay announced that it…

ViewRay announced that it is moving its headquarters to Denver, Colorado. In mid-2019, ViewRay established an office in Denver starting with fewer than ten teammates. ViewRay's presence in Denver has now grown to over 50 teammates with the expansion of the company's international marketing, finance, and legal teams. ViewRay is one of the fastest growing companies in the med-tech sector with plans for considerable growth in Denver. ViewRay expects to continue expanding its Denver team with additional high-paying roles in product development, manufacturing, and quality and, in 2023, the company plans to add another building focused on development, manufacturing, and physician training.

ShowHide Related Items >><<
VRAY ViewRay
$3.40 /

+0.115 (+3.50%)

VRAY ViewRay
$3.40 /

+0.115 (+3.50%)

08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
02/11/22 Piper Sandler
ViewRay should be bought on recent weakness, says Piper Sandler
VRAY ViewRay
$3.40 /

+0.115 (+3.50%)

  • 17
    Nov
VRAY ViewRay
$3.40 /

+0.115 (+3.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.